DRKS00021166已完成不适用
Development of a test to measure the immune response in patients with Covid-19 - CoV-Ak-Test
Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig0 个研究点目标入组 55 人开始时间: 2020年3月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Adults with previous SARS CoV-2 infection
排除标准
- •Pregnancy, individuals unable to provide informed consent
研究者
相似试验
已完成
不适用
Prospective study on evaluation of immune response after SARS-CoV-2 vaccinatioHealthy SubjectJPRN-UMIN000045492Shionogi & Co., Ltd.143
进行中（未招募）
1 期
A prospective study to evaluate the immune response of UK infants receiving the 13-valent pneumococcal conjugate vaccine as part of their routine primary immunisation schedule at 2 and 4 months (code: P13UK) - P13UKPrevenar13 was introduced into the national childhood immunisation programme to prevent serious bacterial infections caused by the germ Streptococcus pneumonia, including meningitis, septicaemia and pneumonia.EUCTR2010-023865-22-GBHealth Protection Agency
已完成
4 期
Responses to booster vaccinations in UK toddlersISRCTN84763401Health Protection Agency (UK)200
已完成
Unknown
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
已完成
不适用
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60